Evaluation of the efficacy of a commercial inactivated genogroup 2b-based porcine epidemic diarrhea virus (PEDV) vaccine and experimental live genogroup 1b exposure against 2b challenge

DOI: 10.1186/s13567-017-0472-z

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text